1/16/2013

Phoenix Cardiac Devices has begun patient enrollment in a clinical study of its Bace system, which is used to treat mitral regurgitation without the need for open-heart procedures. The trial, which will involve 60 patients from Europe and India, will be used to help the company obtain CE mark approval for the device in Europe.

Related Summaries